Your browser is no longer supported. Please, upgrade your browser.
MDNA Medicenna Therapeutics Corp. daily Stock Chart
Medicenna Therapeutics Corp.
Index- P/E- EPS (ttm)- Insider Own33.13% Shs Outstand48.80M Perf Week12.43%
Market Cap203.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float32.57M Perf Month10.64%
Income- PEG- EPS next Q- Inst Own- Short Float0.09% Perf Quarter9.29%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.50 Perf Half Y71.19%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year352.17%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.88 - 5.32 Perf YTD60.00%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-21.80% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low372.73% ATR0.33
Employees7 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.45 Volatility7.70% 7.58%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.20 Prev Close4.05
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume59.49K Price4.16
Recom- SMA201.37% SMA500.89% SMA20022.71% Volume71,106 Change2.72%
Oct-20-20 06:27AM  
Oct-19-20 07:00AM  
Oct-15-20 05:30PM  
Sep-30-20 04:30PM  
Sep-09-20 07:00AM  
Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.